- Home
- ADCT vs GWRS Comparison
ADCT vs GWRS Comparison
Compare ADCT & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- GWRS
- Stock Information
- Founded
- ADCT 2011
- GWRS 2003
- Country
- ADCT Switzerland
- GWRS United States
- Employees
- ADCT N/A
- GWRS N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- GWRS Water Supply
- Sector
- ADCT Health Care
- GWRS Utilities
- Exchange
- ADCT Nasdaq
- GWRS Nasdaq
- Market Cap
- ADCT 241.0M
- GWRS 286.0M
- IPO Year
- ADCT 2020
- GWRS 2010
- Fundamental
- Price
- ADCT $3.17
- GWRS $10.54
- Analyst Decision
- ADCT Strong Buy
- GWRS
- Analyst Count
- ADCT 6
- GWRS 0
- Target Price
- ADCT $7.80
- GWRS N/A
- AVG Volume (30 Days)
- ADCT 913.9K
- GWRS 51.1K
- Earning Date
- ADCT 08-05-2025
- GWRS 08-06-2025
- Dividend Yield
- ADCT N/A
- GWRS 2.89%
- EPS Growth
- ADCT N/A
- GWRS N/A
- EPS
- ADCT N/A
- GWRS 0.23
- Revenue
- ADCT $75,817,000.00
- GWRS $53,539,000.00
- Revenue This Year
- ADCT $11.75
- GWRS $8.31
- Revenue Next Year
- ADCT $10.29
- GWRS $6.52
- P/E Ratio
- ADCT N/A
- GWRS $45.82
- Revenue Growth
- ADCT 10.49
- GWRS 3.94
- 52 Week Low
- ADCT $1.05
- GWRS $9.37
- 52 Week High
- ADCT $4.13
- GWRS $13.98
- Technical
- Relative Strength Index (RSI)
- ADCT 59.73
- GWRS 53.73
- Support Level
- ADCT $2.66
- GWRS $10.09
- Resistance Level
- ADCT $3.30
- GWRS $11.05
- Average True Range (ATR)
- ADCT 0.20
- GWRS 0.30
- MACD
- ADCT 0.01
- GWRS 0.03
- Stochastic Oscillator
- ADCT 90.00
- GWRS 49.60
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.